GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Strides Pharma Science Ltd (NSE:STAR) » Definitions » 12-1 Month Momentum %

Strides Pharma Science (NSE:STAR) 12-1 Month Momentum % : 149.39% (As of Jun. 01, 2024)


View and export this data going back to 2000. Start your Free Trial

What is Strides Pharma Science 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-01), Strides Pharma Science's 12-1 Month Momentum % is 149.39%.

The industry rank for Strides Pharma Science's 12-1 Month Momentum % or its related term are showing as below:

NSE:STAR's 12-1 Month Momentum % is ranked better than
95.95% of 1110 companies
in the Drug Manufacturers industry
Industry Median: -6.34 vs NSE:STAR: 149.39

Competitive Comparison of Strides Pharma Science's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Strides Pharma Science's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Strides Pharma Science's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Strides Pharma Science's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Strides Pharma Science's 12-1 Month Momentum % falls into.



Strides Pharma Science  (NSE:STAR) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Strides Pharma Science  (NSE:STAR) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Strides Pharma Science 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Strides Pharma Science's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Strides Pharma Science (NSE:STAR) Business Description

Traded in Other Exchanges
Address
Strides House, Bannerghatta Road, Bilekahalli, Bengaluru, KA, IND, 560 076
Strides Pharma Science Ltd is a specialty and generic drug manufacturer. The company focuses on developing niche and complex pharmaceutical products across therapeutic segments for regulated and emerging markets. Strides' emerging-market strategy focuses on branded generics for the treatment of chronic therapies. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Strides Pharma Science (NSE:STAR) Headlines

No Headlines